급성 심부전의 혈역학적 감시와 치료
Hemodynamic Monitoring and Treatment Strategy of Acute Heart Failure
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Acute heart failure (AHF) has emerged as a major public health problem over the past 2 decades and AHF represents a period of high risk for patients, during which time the patients are more susceptible to have fatal outcomes or be re-hospitalized, compared to periods of chronic stable heart failure. The goals of AHF treatment are symptomatic relief and hemodynamic stabilization, which need accurate assessment of volume status and cardiac function of patients. Until now, there is a paucity of controlled clinical data to define optimal treatment for patients with AHF and most guidelines published by the American Heart Association or European Society of Cardiology have been generated by the consensus opinions of experts. In these guidelines, routine invasive hemodynamic monitoring of AHF patients is not recommended because there have not been any reports showing survival benefit in patients monitored with pulmonary artery catheters. At present, treatment strategies based on clinical characteristics such as pulmonary congestion and tissue hypoperfusion rather than invasive hemodynamic monitoring is widely accepted. In this article, we discuss an optimal management plan including appropriate assessment of the hemodynamic status of patients and treatment of AHF.
Abstract
Acute heart failure (AHF) has emerged as a major public health problem over the past 2 decades and AHF represents a period of high risk for patients, during which time the patients are more susceptible to have fatal outcomes or be re-hospitalized, compared to periods of chronic stable heart failure. The goals of AHF treatment are symptomatic relief and hemodynamic stabilization, which need accurate assessment of volume status and cardiac function of patients. Until now, there is a paucity of controlled clinical data to define optimal treatment for patients with AHF and most guidelines published by the American Heart Association or European Society of Cardiology have been generated by the consensus opinions of experts. In these guidelines, routine invasive hemodynamic monitoring of AHF patients is not recommended because there have not been any reports showing survival benefit in patients monitored with pulmonary artery catheters. At present, treatment strategies based on clinical characteristics such as pulmonary congestion and tissue hypoperfusion rather than invasive hemodynamic monitoring is widely accepted. In this article, we discuss an optimal management plan including appropriate assessment of the hemodynamic status of patients and treatment of AHF.
참고문헌 (30)
- "Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators", Lancet, 350, pp.1417~1424 (1997)
- McCullough PA, "Resource Utilization Among Congestive Heart Failure (REACH) Study: Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study", J Am Coll Cardiol, 39, pp.60~69 (2002)
- Cleland JG, "Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology: The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis", Eur Heart J, 24, pp.442~463 (2003)
- Fox KF, "Coronary artery disease as the cause of incident heart failure in the population", Eur Heart J, 22, pp.228~236 (2001)
- Al-Khadra AS, "Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction", J Am Coll Cardiol, 31, pp.749~753
- Berry C, "Economics of chronic heart failure", Eur J Heart, 3, pp.283~291 (2001)
- "The treatment of heart failure, In Task Force of the Working Group on Heart Failure of the European Society of Cardiology", Eur Heart J, 18, pp.736~753 (1997)
- Adams KF Jr, "Clinical definition and epidemiology of advanced heart failure", Am Heart J, 135, pp.204~215 (1998)
- O'Connell JB, "The economic burden of heart failure", Clin Cardiol, 23(3), pp.6~10 (2000)
- Stevenson R, "Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis", BMJ, 307, pp.349~353 (1993)
- Roguin A, "Long-term prognosis of acute pulmonary oedema--an ominous outcome", Eur J Heart, 2, pp.137~144 (2000)
- Krumholz HM, "Readmission after hospitalization for congestive heart failure among Medicare beneficiaries", Arch Intern Med, 157, pp.99~104 (1997)
- Krumholz HM, "Admission to hospitals with on-site cardiac catheterization facilities: impact on long-term costs and outcomes", Circulation, 98, pp.2010~2016 (1998)
- Cowie MR, "The epidemiology of heart failure", Eur Heart J, 18, pp.208~225 (1997)
- McAlister FA, "A systematic review of randomized trials of disease management programs in heart failure", Am J Med, 110, pp.378~384 (2001)
- Krumholz HM, "Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age", Am J Cardiol, 79, pp.581~586 (1997)
- Rich MW, "A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure", N Engl J Med, 333, pp.1190~1195 (1995)
- Killip T 3rd, "Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients", Am J Cardiol, 20, pp.457~464 (1967)
- Forrester JS, "Correlative classification of clinical and hemodynamic function after acute myocardial infarction", Am J Cardiol, 39, pp.137~145 (1977)
- Dao Q, "Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting", J Am Coll Cardiol, 37, pp.379~385 (2001)
- Cowie MR, "Clinical applications of B-type natriuretic peptide (BNP) testing", Eur Heart J, 24, pp.1710~1718 (2003)
- Nagueh SF, "Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures", J Am Coll Cardiol, 30, pp.1527~1533 (1997)
- Marik PE, "Pulmonary artery catheterization and esophageal doppler monitoring in the ICU", Chest, 116, pp.1085~1091 (1999)
- Jardin F, "Invasive monitoring combined with two-dimensional echocardiographic study in septic shock", Intensive Care Med, 20, pp.550~554 (1994)
- Gore JM, "A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction", Chest, 92, pp.721~727 (1987)
- Zion MM, "Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5841 patients in the SPRINT Registry", Chest, 98, pp.1331~1335 (1990), SPRINT Study Group
- Connors AF Jr, "The effectiveness of right heart catheterization in the initial care of critically ill patients", JAMA, 276, pp.889~897 (1996), SUPPORT Investigators
- Ivanov R, "The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: a meta-analysis", Crit Care Med, 28, pp.615~619 (2000)
- Rhodes A, "A randomised, controlled trial of the pulmonary artery catheter in critically ill patients", Intensive Care Med, 28, pp.256~264 (2002)
- Mueller HS, "ACC expert consensus document. Present use of bedside right heart catheterization in patients with cardiac disease", J Am Coll Cardiol, 32, pp.840~864 (1998), American College of Cardiology